Delivering high-value, low-volume products to market
The increasing desire for new variants of products is constantly driving the need for innovation in research. The commercial success of new personalised products, from skin care lotions to vaccines, often lies, not only in safely controlling the characteristics of the active ingredients and in the reproducibility of the formulation, but also in delivering the end product to market quickly, safely and at an appropriate scale.
By automating the design of experiment (DoE) stage in continuous flow manufacturing, agile development and scale-up processes are integrated seamlessly into robust, commercially-viable manufacturing processes. This offers the opportunity to fast-track product development and reformulation to meet ever-changing market demand.
This Optimised Experimental Design Platform (OEDP) enables the adoption of modern experimental design, the integration of PAT and precision model-based control. By embedding this functionality into a single containerised platform, the management of flow reactors is streamlined to deliver new products to market safely and efficiently.
The scale and precise control of this technique enables continuous production under extreme processing conditions, managing aggressive media, handling unstable intermediates and potentially hazardous reactions that are not feasible under batch conditions.
Download our overview of the Optimized Experimental Design Platform for continuous flow reactors
